BLUEBIRD BIO INC (BLUE)
US09609G1004 - Common Stock
ChartMill assigns a Buy % Consensus number of 72% to BLUE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.24. This target is 359.58% above the current price.
BLUE was analyzed by 20 analysts. The buy percentage consensus is at 72. So analysts seem to be have mildly positive about BLUE.
In the previous month the buy percentage consensus was at a similar level.
BLUE was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-03-27 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2024-03-27 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-03-19 | Wedbush | Maintains | Neutral -> Neutral |
| 2024-03-05 | HSBC | Maintains | Reduce -> Reduce |
| 2023-12-21 | B of A Securities | Maintains | Buy -> Buy |
| 2023-12-15 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2023-12-12 | Baird | Maintains | Outperform -> Outperform |
| 2023-12-11 | B of A Securities | Maintains | Buy -> Buy |
| 2023-12-08 | Morgan Stanley | Upgrade | Underweight -> Equal-Weight |
| 2023-11-08 | Raymond James | Maintains | Outperform -> Outperform |
| 2023-10-17 | Cantor Fitzgerald | Initiate | Neutral |
| 2023-09-06 | HSBC | Initiate | Buy |
| 2023-07-19 | B of A Securities | Upgrade | Neutral -> Buy |
| 2023-07-11 | Morgan Stanley | Reiterate | Underweight -> Underweight |
| 2023-06-01 | Barclays | Upgrade | Equal-Weight -> Overweight |
| 2023-04-28 | JP Morgan | Initiate | Overweight |
| 2023-04-03 | Morgan Stanley | Maintains | Underweight |
| 2023-03-30 | RBC Capital | Reiterate | Sector Perform |
| 2023-03-30 | B of A Securities | Maintains | Neutral |
| 2023-03-07 | Baird | Initiate | Outperform |
| 2023-01-24 | Morgan Stanley | Maintains | Underweight |
| 2023-01-23 | SVB Leerink | Maintains | Market Perform |
| 2023-01-06 | SVB Leerink | Maintains | Market Perform |
| 2022-11-08 | RBC Capital | Maintains | Sector Perform |
| 2022-09-20 | Raymond James | Maintains | Outperform |
| 2022-08-19 | Goldman Sachs | Maintains | Sell |
| 2022-08-18 | SVB Leerink | Maintains | Market Perform |
| 2022-08-05 | Barclays | Upgrade | Underweight -> Equal-Weight |
| 2022-08-02 | Raymond James | Upgrade | Market Perform -> Outperform |
| 2022-05-24 | Goldman Sachs | Maintains | Sell |